Species-specific pharmacology of maximakinin, an amphibian homologue of bradykinin: putative prodrug activity at the human B(2) receptor and peptidase resistance in rats

por Charest-Morin, Xavier, Bachelard, Hélène, Jean, Melissa, Marceau, Francois
Publicado 2017

In Vivo Effects of Bradykinin B(2) Receptor Agonists with Varying Susceptibility to Peptidases

por Jean, Mélissa, Gera, Lajos, Charest-Morin, Xavier, Marceau, François, Bachelard, Hélène
Publicado 2016

Infrared-emitting, peptidase-resistant fluorescent ligands of the bradykinin B(2) receptor: application to cytofluorometry and imaging

por Gera, Lajos, Charest-Morin, Xavier, Jean, Melissa, Bachelard, Hélène, Marceau, François
Publicado 2016

Pharmacological effects of recombinant human tissue kallikrein on bradykinin B(2) receptors

por Charest-Morin, Xavier, Raghavan, Arvind, Charles, Matthew L, Kolodka, Tadeusz, Bouthillier, Johanne, Jean, Mélissa, Robbins, Mark S, Marceau, François
Publicado 2015

Phase II study of pembrolizumab in refractory esophageal cancer with correlates of response and survival

por de Klerk, Leonie K, Patel, Anuj K, Derks, Sarah, Pectasides, Eirini, Augustin, Jeremy, Uduman, Mohamed, Raman, Nihal, Akarca, Fahire G, McCleary, Nadine J, Cleary, James M, Rubinson, Douglas A, Clark, Jeffrey W, Fitzpatrick, Bridget, Brais, Lauren K, Cavanaugh, Megan E, Rode, Amanda J, Jean, Melissa G, Lizotte, Patrick H, Nazzaro, Matthew J, Severgnini, Mariano, Zheng, Hui, Fuchs, Charles S, Enzinger, Peter C, Bass, Adam J
Publicado 2021